These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 9230743

  • 1. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
    King M, Dasgupta B, Tomkiewicz RP, Brown NE.
    Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
    [Abstract] [Full Text] [Related]

  • 2. Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase.
    Dasgupta B, King M.
    Pediatr Pulmonol; 1996 Sep; 22(3):161-6. PubMed ID: 8893254
    [Abstract] [Full Text] [Related]

  • 3. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
    Feng W, Garrett H, Speert DP, King M.
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
    [Abstract] [Full Text] [Related]

  • 4. Effects of sputum oscillations and rhDNase in vitro: a combined approach to treat cystic fibrosis lung disease.
    Dasgupta B, Brown NE, King M.
    Pediatr Pulmonol; 1998 Oct; 26(4):250-5. PubMed ID: 9811074
    [Abstract] [Full Text] [Related]

  • 5. Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.
    Suri R, Marshall LJ, Wallis C, Metcalfe C, Bush A, Shute JK.
    Am J Respir Crit Care Med; 2002 Aug 01; 166(3):352-5. PubMed ID: 12153969
    [Abstract] [Full Text] [Related]

  • 6. Effects of combined treatment with rhDNase and airflow oscillations on spinnability of cystic fibrosis sputum in vitro.
    Dasgupta B, Tomkiewicz RP, Boyd WA, Brown NE, King M.
    Pediatr Pulmonol; 1995 Aug 01; 20(2):78-82. PubMed ID: 8570306
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R, Metcalfe C, Wallis C, Bush A.
    Pediatr Pulmonol; 2004 Apr 01; 37(4):305-10. PubMed ID: 15022126
    [Abstract] [Full Text] [Related]

  • 10. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial.
    Suri R, Metcalfe C, Lees B, Grieve R, Flather M, Normand C, Thompson S, Bush A, Wallis C.
    Lancet; 2001 Oct 20; 358(9290):1316-21. PubMed ID: 11684212
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Recombinant human DNase (rhDNase) influences phospholipid composition, surface activity, rheology and consecutively clearance indices of cystic fibrosis sputum.
    Griese M, App EM, Duroux A, Burkert A, Schams A.
    Pulm Pharmacol Ther; 1997 Oct 20; 10(1):21-7. PubMed ID: 9344829
    [Abstract] [Full Text] [Related]

  • 13. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
    Hansen G, Hoffjan S, Mosler K, Schuster A.
    Lung; 2001 Oct 20; 179(3):185-94. PubMed ID: 11891608
    [Abstract] [Full Text] [Related]

  • 14. Improved activity of an actin-resistant DNase I variant on the cystic fibrosis airway secretions.
    Zahm JM, Debordeaux C, Maurer C, Hubert D, Dusser D, Bonnet N, Lazarus RA, Puchelle E.
    Am J Respir Crit Care Med; 2001 Apr 20; 163(5):1153-7. PubMed ID: 11316652
    [Abstract] [Full Text] [Related]

  • 15. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis.
    Henry RL, Gibson PG, Carty K, Cai Y, Francis JL.
    Pediatr Pulmonol; 1998 Aug 20; 26(2):97-100. PubMed ID: 9727759
    [Abstract] [Full Text] [Related]

  • 16. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.
    Robinson M, Regnis JA, Bailey DL, King M, Bautovich GJ, Bye PT.
    Am J Respir Crit Care Med; 1996 May 20; 153(5):1503-9. PubMed ID: 8630593
    [Abstract] [Full Text] [Related]

  • 17. Additive effect of dornase alfa and Nacystelyn on transportability and viscoelasticity of cystic fibrosis sputum.
    Sun F, Tai S, Lim T, Baumann U, King M.
    Can Respir J; 2002 May 20; 9(6):401-6. PubMed ID: 12522485
    [Abstract] [Full Text] [Related]

  • 18. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
    Bilton D, Stanford G.
    Curr Opin Pulm Med; 2014 Nov 20; 20(6):601-6. PubMed ID: 25221855
    [Abstract] [Full Text] [Related]

  • 19. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
    Laube BL, Auci RM, Shields DE, Christiansen DH, Lucas MK, Fuchs HJ, Rosenstein BJ.
    Am J Respir Crit Care Med; 1996 Feb 20; 153(2):752-60. PubMed ID: 8564129
    [Abstract] [Full Text] [Related]

  • 20. Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis.
    Suri R, Grieve R, Normand C, Metcalfe C, Thompson S, Wallis C, Bush A.
    Thorax; 2002 Oct 20; 57(10):841-6. PubMed ID: 12324668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.